SCHEMBL21067706

SCHEMBL21067706

N[C@@H](CO[P@@](=O)(O)OC[C@@H](O)CO)C(=O)O

nearest known ligand 0.56

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
P2RY10 O00398 16/20 0.56
GPR174 Q9BXC1 10/20 0.56
GPR34 Q9UPC5 7/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30244695 1.00 P2RY10 (0.56) P2RY10GPR174GPR34
SCHEMBL29715574 1.00 P2RY10 (0.56) P2RY10GPR174GPR34
SCHEMBL22219423 1.00 P2RY10 (0.56) P2RY10GPR174GPR34
SCHEMBL2017576 1.00 P2RY10 (0.56) P2RY10GPR174GPR34
SCHEMBL13863415 1.00 P2RY10 (0.56) P2RY10GPR174GPR34
Dexfosfoserine SCHEMBL28051238 0.84 PGK1 (0.53) P2RY10GPR174GPR34
SCHEMBL30244795 0.83 P2RY10 (0.41) P2RY10GPR174GPR34
SCHEMBL29556656 0.83 P2RY10 (0.41) P2RY10GPR174GPR34
SCHEMBL13618513 0.83 P2RY10 (0.60) P2RY10GPR174GPR34
SCHEMBL12284729 0.83 SMN1; SMN2 (0.46) P2RY10GPR174GPR34

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11446398-B2 Regulated biocircuit systems OBSIDIAN THERAPEUTICS, INC. (US) 2022-09-20 US disclosed
US-20190192691-A1 REGULATED BIOCIRCUIT SYSTEMS OBSIDIAN THERAPEUTICS, INC. 2019-06-27 US disclosed